Council for Cardiology Practice
- Guidelines in Practice: cardiovascular prevention, what are the take-home messages for the general practitioner?
- Meet the Experts: cardiovascular care in complex elderly patients
- From risk factor management to treatment optimisation in patients with cardiac disease
- Optimising the interface between primary and secondary care: from acute to chronic management – Organised in collaboration with the ESC Council for Cardiology Practice and the Netherlands Society of Cardiology
- Novel drug therapies in hypertension: new kids on the block
- Novel antithrombotic therapies in cardiovascular disease: what’s on the horizon?
- When the diet does not work: pharmacological options for obesity
- Emerging cardiovascular drugs: watch this space
- Targeting lipids above and beyond statins: key new players
- Heart-brain interactions: sex differences and impact on cognition
- The spectrum of cardiomyopathies: genetics to HIV
- Gene editing and gene therapies to cure cardiovascular diseases
- Mechanisms of ageing in cardiovascular disease
- Personalised treatment of cardiac arrhythmias: novel insights from the bench
- New treatment targets for personalised therapy in genetic cardiomyopathies
- Novel players in atrial fibrillation: looking outside the box
- Vascular and immune control of organ function
- RNA as target and therapeutic tool in cardiovascular diseases
- Circadian rhythm alterations in cardiovascular diseases
- Emerging risk factors for cardiovascular diseases
- Heart-brain and brain-heart interactions in cardiovascular health and disease
- The molecular hallmarks of cardiovascular health
- Therapeutic modulation of the immune system in cardiovascular diseases
- The role of '-omics' in personalised cardiovascular medicine
- Metabolic rewiring of the heart
- Anti-inflammatory therapies: from bench to bedside
- International partnership to nurture future cardiovascular research leaders in Europe
Council on Hypertension
- Great Debate: blood pressure thresholds in hypertension - treat the cardiovascular risk, not the number!
- The floor is yours: bring your questions on renal denervation in hypertension management - when? how? and who?
- Secondary causes of hypertension: mind the gap
- Wearables and digital tools in hypertension management: ready for prime time?
- Clinical Case Management: impact of comorbidities on personalised care for hypertension
- Hot papers in hypertension 2023/2024
- Global approach to hypertension management and cardiovascular risk reduction
- Personalised hypertension management
- Managing hypertension through lifestyle modifications: an important consideration
- Novel drug therapies in hypertension: new kids on the block
- How will digital technologies improve the personalised management of atrial fibrillation
- Subclinical and device-detected atrial fibrillation: fact and fiction
- The floor is yours: bring your questions on stroke prevention in clinical and subclinical atrial fibrillation
- Management of atrial fibrillation: knowns and unknowns
- Great Debate: blood pressure thresholds in hypertension - treat the cardiovascular risk, not the number!
- Global approach to hypertension management and cardiovascular risk reduction
- Novel antithrombotic therapies in cardiovascular disease: what’s on the horizon?
- Hot topics in stroke for cardiologists
- The floor is yours: bring your questions on minimising the risk of stroke during cardiovascular interventions
- Great Debates: acute stroke intervention - what's next after thrombectomy?
- Implementing wearables in neuro-cardiovascular care
- Personalised stroke management
- Heart-brain interactions: sex differences and impact on cognition
- Heart-brain and brain-heart interactions in cardiovascular health and disease
Council on Cardiovascular Genomics
- TBC
- Cardiovascular disease management in patients with cancer. Joint session with the European Society for Medical Oncology (ESMO)
- Guidelines in Practice: personalised imaging a heart failure patient undergoing cancer therapy
- Guidelines in Practice: chest pain and dyspnoea in a patient actively treated for cancer
- Personalising antithrombotic therapy in patients with cancer: what every cardiologist should know
- Guidelines in Practice: a patient with recent non-ST elevation myocardial infarction and percutaneous coronary intervention requiring cancer surgery
- Preventing breast cancer cardiotoxicity with CARDIOCARE
- Cardio-oncology in practice
- Daily cardiac problems in cancer patients
- How to manage acute cardiac problems in patients with cancer
- Challenges when caring for cancer patients with heart disease
Our mission: To reduce the burden of cardiovascular disease.